Regulatory Writing Services
Regulatory writing turns your clinical, non-clinical and quality data into the structured submission documents that health authorities expect, written to international standards and ready for review. At EvySaif, our regulatory writing services support pharmaceutical, biotech and diagnostics companies preparing dossiers for India’s CDSCO, the US FDA, the European EMA and Middle East regulators. We author clear, consistent, submission-ready documents that help your application move through review with fewer queries and faster turnaround.
- What regulatory writing covers
Regulatory writing spans the full Common Technical Document (CTD) and its electronic format (eCTD). Our writers prepare Module 2 summaries, which include the Clinical Overview, the Non-Clinical Overview, and the written and tabulated summaries that condense your evidence for the reviewer, as well as the briefing documents, meeting requests and regulatory response letters that keep a submission on track. Every document is built around the relevant ICH guidance and the specific expectations of your target authority, so your dossier reads as one coherent, defensible scientific argument rather than a collection of separate reports.
- CTD and eCTD Module 2 summaries: Clinical Overview, Non-Clinical Overview, Clinical Summary, Quality Overall Summary
- Briefing documents for scientific advice and pre-submission meetings
- Clinical and non-clinical study summaries for inclusion in regulatory dossiers
- Regulatory response documents: answers to authority queries and deficiency letters
- Investigator’s Brochures (IBs) and updates (see also our protocol and safety pages)
- India-specific submission support under the New Drugs and Clinical Trials Rules, 2019 (Form CT-04 and related dossier components)
Regulatory writing support is for sponsors, CROs, generic and biosimilar manufacturers, and diagnostics companies who need experienced regulatory authoring without building a permanent in-house team. Whether you are filing your first application or scaling a pipeline, we plug in at document level or across a full submission.
EvySaif is one of the best research and medical writing consultancies in India, and we bring that standard to every project. Our regulatory writing is led by a qualified clinical pharmacist (PharmD), which means your documents are reviewed by someone who understands the clinical substance, not just the format. We work to current ICH guidance and align each document to your target market, whether that is India, the GCC, the EU or the US, and we deliver at consultancy pricing that suits emerging and mid-size sponsors. Clarity, consistency and traceability across every document in the dossier are the standard we hold ourselves to.
- Frequently asked questions
What is the difference between regulatory writing and medical writing?
Medical writing is the broader discipline. Regulatory writing is the subset focused specifically on documents submitted to health authorities, such as CTD modules, dossier summaries, briefing documents and regulatory correspondence. EvySaif offers both.
Do you write for CDSCO submissions in India?
Yes. We prepare dossier components aligned with the New Drugs and Clinical Trials Rules, 2019, and the CTD structure CDSCO expects, alongside FDA, EMA and Middle East submissions.
Can you work from our existing study reports and data?
Yes. We author summaries and overviews directly from your CSRs, non-clinical reports and quality data, keeping language consistent across the dossier.